[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]


  The Senate and House are considering an amendment to the HSS
  appropriation that would extend for 5 years the Taxol monopoly, in
  exchange for 3 percent of net sales, for biomedical research.  
  Basically levying a heavy tax on cancer patients to fund more medical
  research, which will give given away as more corporate welfare.
  James Love | Center for Study of Responsive Law
  P.O. Box 19367 | Washington, DC 20036 | http://www.cptech.org
  voice 202.387.8030 | fax 202.234.5176 | love@cptech.org